Malaysia Baby Care Product Rules

Baby care products — baby lotion, body wash, shampoo, massage oil, powder, baby wipes — are cosmetics in Malaysia, managed by NPRA under CDCR 1984 via notification, following the same CNH notification, PIF, GMP, labelling and claims framework as adult cosmetics. What really needs extra care are the two things baby products most easily trip over: the moment a claim mentions "treatment" it becomes a drug, and the stricter safety and ingredient checks for the infant group.

Cosmetic, drug or medical device? Nappy rash is the dividing line

Under item 27 "skin barrier products" of NPRA's MDDCI Product Classification Table, the same cream falls into different boxes depending on the claim:

So ordinary baby lotions, powders and body washes are cosmetics as long as they are positioned for cleaning, moisturising and maintaining normal skin condition; but once a nappy rash cream claims to "prevent/treat nappy rash", it is classified as a drug and must go through registration. In addition, under the Guideline for Cosmetic Claims (Annex I, Part 8), "nappy rash" along with eczema, atopic dermatitis and cradle cap are all listed as skin diseases that may not be claimed — and baby products particularly often cross the line here. For the borderline between efficacy and cosmetics, see Is an Ointment a Drug or a Cosmetic? The Efficacy Claim Borderline.

Permitted and prohibited claims

• May state: gentle cleansing, moisturising, nourishing, soothing (within the cosmetic scope), keeping skin soft, low irritation.
• May not state: treating / preventing nappy rash, eczema, atopic dermatitis, cradle cap; anti-inflammatory; repairing damaged/injured skin; absolute-safety wording such as "no side effects" or "pure natural so absolutely safe" (the guideline expressly disallows "No side effects", and natural does not equal safe).

Ingredients and safety: more conservative for the infant group

Ingredients of baby care products must all comply with the permitted/restricted/prohibited lists of the various annexes of the ASEAN Cosmetic Directive (ACD). In practice, pay special attention to:

• Talc in powder: should meet the ACD purity requirements (industry standard is asbestos-free), and it is recommended to label a caution to avoid puffing near the mouth and nose and to keep away from the baby's face to prevent inhalation.
• Preservatives and fragrance allergens: baby product formulations should be more conservative, and fragrance allergens must be listed when they reach the levels set by the ACD.
• Safety assessment and PIF: a baby product's Product Information File should have sufficient safety assessment support, which is a focus during NPRA's post-market surveillance (PMS) checks after notification.

For the ingredient prohibited/restricted list and INCI labelling, see Cosmetic Ingredients INCI and Prohibited/Restricted. In practice, baby body washes and shampoos often emphasise "tear-free formula" and "gentle and non-irritating" — these are permitted cosmetic appeals; but adding just one line like "helps improve eczema" or "repairs nappy-rash skin" to the copy overturns the whole product's classification, and this is the most common crossing point in baby-brand marketing.

Labelling essentials

Baby cosmetic labels must include: product name and function, full ingredient list (INCI), CNH name and address, manufacturer, net content, batch number, expiry date or Period After Opening (PAO), directions for use and cautions/warnings. For the classification and labelling of baby wipes, see Wet Wipes Classification and Labelling Rules.

Imported and local

Both imported and locally manufactured baby care cosmetics must complete NPRA notification before market entry, under the same rules; the difference is that an imported product's CNH must be a legal entity within Malaysia and responsible for the PIF. The classification borderline (cosmetic vs a drug such as nappy rash cream) and claim red lines do not vary by origin.

Frequently asked questions (FAQ)

Q: Do baby lotion and powder need to be notified? Yes. They are cosmetics and, under CDCR 1984, must first complete NPRA notification and obtain a notification number before sale.

Q: Is nappy rash cream a cosmetic? If it claims to prevent or treat nappy rash, under the MDDCI it is a drug and must be registered rather than notified; only when positioned purely for moisturising and maintaining normal skin condition is it a cosmetic.

Q: Can baby products state "additive-free, absolutely safe"? Not recommended. The guideline disallows absolute-safety wording such as "no side effects/harmless", and natural ingredients must not imply that they are therefore safe.

Q: Are there ingredient restrictions for baby powder? Talc must meet the ACD purity requirements (industry standard is asbestos-free), the formulation must pass safety assessment, and adding an inhalation-avoidance caution is recommended.

Q: Is the safety assessment for baby products stricter? The framework is the same, but because the user group is sensitive, the PIF's safety assessment should be more thorough, and it is a common focus of NPRA post-market surveillance checks.

Pre-market self-check

• [ ] NPRA cosmetic notification completed
• [ ] No claims to treat/prevent nappy rash, eczema, atopic dermatitis or cradle cap
• [ ] No prohibited wording such as "no side effects/absolutely safe"
• [ ] Ingredients comply with ACD permitted/restricted/prohibited lists; talc purity met
• [ ] Fragrance allergens listed as required; PIF safety assessment complete
• [ ] Label includes ingredient list, CNH information, batch number, expiry/PAO and warnings

Summary: The key to keeping baby care products a cosmetic is to lock the positioning on cleaning and moisturising, touch no disease-treatment claims, and adopt a more conservative standard on ingredients and safety. To grasp the full picture of notification first, see the pillar Malaysia Cosmetic Regulations Guide.

Run a free label check now

This article is compiled from official sources for reference only; actual compliance is subject to the latest official text and review by the competent authority.